Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

These diseases require specialty treatment typically unavailable at local retail pharmacies or small health systems, making ...

Liver fibrosis often develops without symptoms and has no approved cure. But researchers at the University of Sunderland have ...

The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury ...

NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation ...